Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25441801.
- Also identified by DOI 10.1016/j.athoracsur.2014.01.076.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acute pulmonary embolism is considered a contraindication to lung donation for transplantation as it might result in graft dysfunction. Ex vivo lung perfusion (EVLP) is a novel method to assess and recondition a questionable donor graft before transplantation. In this report we present a case of successful bilateral lung transplant after donor lung assessment and treatment with a fibrinolytic agent, urokinase, during EVLP.
Medical subject headings
- Cystic Fibrosis
- Extracorporeal Circulation
- Lung Transplantation
- Reperfusion
- Tissue Donors
- Urokinase-Type Plasminogen Activator